AQR Capital Management’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-65,296
| Closed | -$1.87M | – | 2287 |
|
|
2018
Q4 | $1.87M | Buy |
65,296
+2,992
| +5% | +$85K | ﹤0.01% | 1271 |
|
|
2018
Q3 | $1.74M | Hold |
62,304
| – | – | ﹤0.01% | 1457 |
|
|
2018
Q2 | $1.74M | Hold |
62,304
| – | – | ﹤0.01% | 1489 |
|
|
2018
Q1 | $1.55M | Hold |
62,304
| – | – | ﹤0.01% | 1471 |
|
|
2017
Q4 | $1.51M | Sell |
62,304
-545
| -0.9% | -$14.4K | ﹤0.01% | 1503 |
|
|
2017
Q3 | $1.74M | Buy |
62,849
+41,537
| +195% | +$1.11M | ﹤0.01% | 1429 |
|
|
2017
Q2 | $534K | Buy |
21,312
+6,598
| +45% | +$163K | ﹤0.01% | 1864 |
|
|
2017
Q1 | $395K | Sell |
14,714
-5,109
| -26% | -$141K | ﹤0.01% | 1950 |
|
|
2016
Q4 | $520K | Sell |
19,823
-3,143
| -14% | -$77.7K | ﹤0.01% | 1914 |
|
|
2016
Q3 | $574K | Buy |
22,966
+4,579
| +25% | +$107K | ﹤0.01% | 1902 |
|
|
2016
Q2 | $399K | Sell |
18,387
-12,338
| -40% | -$220K | ﹤0.01% | 1942 |
|
|
2016
Q1 | $461K | Sell |
30,725
-44,775
| -59% | -$750K | ﹤0.01% | 1865 |
|
|
2015
Q4 | $1.66M | Sell |
75,500
-10,564
| -12% | -$197K | ﹤0.01% | 1332 |
|
|
2015
Q3 | $1.36M | Buy |
86,064
+14,060
| +20% | +$225K | ﹤0.01% | 1292 |
|
|
2015
Q2 | $1.03M | Buy |
72,004
+5,804
| +9% | +$98.3K | ﹤0.01% | 1480 |
|
|
2015
Q1 | $1.15M | Buy |
66,200
+36,700
| +124% | +$648K | ﹤0.01% | 1355 |
|
|
2014
Q4 | $529K | Buy |
+29,500
| New | +$475K | ﹤0.01% | 1940 |
|
|
2014
Q3 | – | Sell |
-12,100
| Closed | -$174K | – | 2634 |
|
|
2014
Q2 | $174K | Sell |
12,100
-16,400
| -58% | -$214K | ﹤0.01% | 2399 |
|
|
2014
Q1 | $363K | Buy |
+28,500
| New | +$372K | ﹤0.01% | 2183 |
|
Other funds holding NXTM
AQR Capital Management's NXTM Position: Q1 2019 in Review
AQR Capital Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 65,296 shares — an estimated $1.87M sold.
AQR Capital Management first reported a position in NXTM in Q1 2014 and held it in 19 quarters. The position peaked at $1.87M in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- AQR Capital Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- AQR Capital Management sold 65,296 NxStage Medical Inc. shares in Q1 2019, an estimated $1.87M.
- AQR Capital Management first reported a position in NxStage Medical Inc. in Q1 2014 and held it in 19 quarters.
- AQR Capital Management's NxStage Medical Inc. position peaked at $1.87M in Q4 2018.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on AQR Capital Management's 13F filing for Q1 2019, filed 14 May 2019.